The hospital’s for-profit hospital HCA Healthcare is benefiting from a rebound in patient traffic this year following a 2020 disaster marked by COVID-19 stops and anxious patients delaying care.
HCA’s admissions jumped 17.5% year on year in the second quarter of 2021, which ended June 30th. The biggest gains have been made in outpatient visits, emergency room visits and emergency room visits, the company revealed in its balance sheet.
These signs back to normal events such as people with COVID-19 comprise a declining share of patients in the 187 HCA hospitals. Only 3% of HCA patients were treated for COVID-19 during the second trimester compared with 10% in the previous year’s period, Sam Hazen, CEO of the Nashville, Tennessee company, said Tuesday in a call with investors.
Overcoming the poor performance by the second quarter of 2020, when COVID-19 spread virtually uncontrollably, was not difficult now that the virus has become less prevalent. To better demonstrate the company’s financial results, HCA indicated the second quarter of 2019, which happened well before the start of the new coronavirus pandemic, as a better comparison. Admissions were up 2.7%, and outpatient surgeries were up 3.4% during the second quarter of this year compared to the same months in 2019. Internal surgery cases are up. were down 2.9% and emergency room visits — the slowest to recover — fell 5.5%.
More patients seeking elective procedures, sympathetic people were more likely to quit during the worst pandemic treatments contributed to 34% higher annual profits in the second quarter of 2021, from $ 1.1 billion to nearly $ 1.5 billion in the second quarter of last year. During the first six months of this year, profits grew 73% from $ 1.7 billion in the first half of the 2020 period to $ 2.9 billion as of June this year.
HCA collected $ 14.4 billion in revenue during the second quarter of 2021, 30% higher than its $ 11.1 billion in revenue over the period a year ago.
HCA has revised up its projected revenues and earnings year-over-year projections made in the first quarter The company now expects that 2021 revenues could reach $ 58 billion, at least $ 4 billion more than previously projected.